Efficient EFV600mg+FTC200mg+TDF300mg HIV-1 Tabs - Comprehensive HIV Treatment Option
ProcurenetShort description
Highly Effective EFV600mg+FTC200mg+TDF300mg Tabs for Comprehensive HIV-1 Treatment
- Comprehensive HIV-1 antiretroviral therapy featuring Efavirenz (600mg), Emtricitabine (200mg), and Tenofovir Disoproxil Fumarate (300mg)
- Acts as a Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI), Nucleoside Reverse Transcriptase Inhibitor (NRTI), and Nucleotide Reverse Transcriptase Inhibitor (NtRTI)
- Orally administer once daily on an empty stomach before sleep; Helps to reduce potential CNS side effects
- 30-film-coated tablets per pack, with a shelf-life of up to 24 months from the manufacture date
- Recommended storage: Keep below 30°C in the original packaging, kept away from children’s access
-
Procurenet Team Tshim Sha Tsui
Hong Kong
3 years
Description
Highly Efficient EFV600mg+FTC200mg+TDF300mg Tabs for Comprehensive HIV-1 Treatment
Embrace a potent and comprehensive management of HIV-1 infection with the EFV600mg+FTC200mg+TDF300mg Tabs. This film-coated tablet regimen is a robust blend of 600mg Efavirenz, 200mg Emtricitabine, and 300mg Tenofovir Disoproxil Fumarate, intricately designed for maximum therapeutic benefits.
- Therapeutic Potency: Enjoy the full coverage of HIV-1 therapeutic options with a unique formulation incorporating 3 different drugs from the NNRTI, NRTI, and NtRTI pharmacological classes, respectively. This blend offers a remarkable record of clinical efficiency and safety.
- Usage Guide: Consumable orally, these tablets are designed to be taken on an empty stomach, ideally before bedtime to reduce CNS side effects. Packaged in a secure container with desiccants for optimum drug stability.
- Evidence-Based Indications: These tablets signify effective management for HIV-1 infection in adults and can be used independently or in combination with other antiretroviral drugs. Dispensation is recommended in the original container to avoid repacking.
- Regulatory Compliance: Aligned with the regulatory approvals, this drug regimen features on the List of WHO Prequalified Medicines and the List of USFDA approved and tentatively approved items.
- Storage Instructions: This medication must be stored below 30°C and kept in its original packaging with a desiccant to maintain efficacy and shelf-life.
- Treatment Guidelines: Follow the WHO's HIV/AIDS resources and their Generic tool for pediatric ARV dosing for more comprehensive information on the dosage schemes.
Remember, always consult healthcare professionals for personalized advice before starting any medication regimen.
